R

R. Lor Randall

University of California Davis Medical Center

ORCID: 0000-0002-3660-774X

426 papers and 12.8k citations.

PubIndex Score67Top 33% · seniorHow it's scored

426Publications

12.8kTotal Citations

First publication: 1950First senior author: 1976

Top publicationsby citations

Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

Margaret von Mehren, Jillian L. Scavone, R. Lor Randall et al.|Journal of the National Comprehensive Cancer Network|2018

Cited by 733

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

Sigbjørn Smeland, Beate Timmermann, Mark C. Gebhardt et al.|European Journal of Cancer|2019

Cited by 724

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

Neyssa Marina, Lisa A. Teot, Sigbjørn Smeland et al.|The Lancet Oncology|2016

Cited by 537

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

Stefan Bielack, Mark L. Bernstein, Sigbjørn Smeland et al.|Journal of Clinical Oncology|2015

Cited by 419

Monogenic and polygenic determinants of sarcoma risk: an international genetic study

Mandy L. Ballinger, David M. Thomas, David L. Goode et al.|The Lancet Oncology|2016

Cited by 213

Indexing the rest of 426 publications…